GoodRx is teaming up with Sanofi to offer consumers access to its most prescribed insulin, Lantus, for $35 at thousands of pharmacies nationwide. All Americans with a valid prescription, regardless of ...
GoodRx announced Thursday morning that it is working with Sanofi on a program to offer one of its leading insulin products to consumers for $35 per month. By visiting ...
More Americans with diabetes will get a break on their insulin costs in 2024. Sanofi is joining the nation's two other major insulin manufacturers in offering either price caps or savings programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results